Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR (PENDING) | Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where Suchitra Sundaram is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series
Epperla, N., Zayac, A. S., Landsburg, D. J., Bock, A. M., Nowakowski, G. S., Ayers, E. C., Girton, M., Hu, M., Beckman, A., Li, S., Medeiros, L. J., Chang, J. E., Kurt, H., Sandoval-Sus, J., Ansari-Lari, M. A., Kothari, S. K., Kress, A., Xu, M. L., Torka, P. & Sundaram, S. & 14 others, , 22 Oct 2024, In: Blood advances. 8, 20, p. 5355-5364 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia
Zablonski, K. G., Skupa, S. A., Eiken, A. P., Sundaram, S., Mavis, C., Gu, J., Torka, P., Ghione, P., El-Gamal, D. & Hernandez-Ilizaliturri, F. J., 2024, In: Leukemia and Lymphoma. 65, 14, p. 2129-2137 9 p.Research output: Contribution to journal › Article › peer-review
-
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
Torka, P., Groman, A., Wong, J., Nichols, J., Kader, A., Mavis, C., Anampa-Guzmán, A., Sait, S. J., Block, A. M., Przespolewski, E., Mohr, A., Lund, I., McWhite, K., Kostrewa, J., DeMarco, J., Johnson, M., Darrall, A., Thomas, R., Sundaram, S. & Ghione, P. & 2 others, , 11 Aug 2023, In: Blood advances. 7, 7, p. 1146-1155 10 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort
Agrawal, P., David, K. A., Chen, Z., Sundaram, S., Kim, S. H., Vaca, R., Lin, Y., Singer, S., Malecek, M. K., Carter, J., Zayac, A., Kim, M. S., Reddy, N., Ney, D., Habib, A., Strouse, C., Graber, J., Bachanova, V., Salman, S. & Vendiola, J. A. & 31 others, , 2023, In: Leukemia and Lymphoma. 64, 5, p. 1026-1034 9 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes
Wagner, C. B., Boucher, K., Nedved, A., Micallef, I. N., Desai, S., Hatic, H., Goyal, G., Zacholski, E., Fegley, A., Sigmund, A. M., Bond, D. A., Samuels, C., Kamdar, M. K., Aqeel, S. B., Torka, P., MacDougall, K., Borogovac, A., Rajeeve, S., Sundaram, S. & Fedak, K. & 10 others, , Nov 2023, In: Haematologica. 108, 11, p. 3025-3032 8 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations
Press/Media
-
Venetoclax Regimens for 'Fit' CLL Yield High Undetectable MRD Rates
13/12/21
1 item of Media coverage
Press/Media
-